Show results for
Refine by
Neurodegeneration Suppliers Serving Croatia
33 companies found
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inSeillans, FRANCE
RespInnovation SAS designs, develops and markets the RespIn 11 Bronchial Clearance System. A focused pulse bronchial clearance system based on high frequency chest wall oscillation (HFCWO) therapy for the treatment of many diseases with chronic ...
based inEncinitas, CALIFORNIA (USA)
Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...
The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inBerwyn, PENNSYLVANIA (USA)
Virpax Pharmaceuticals specializes in developing novel and proprietary drug-delivery systems across various pain and CNS disorder indications to enhance compliance and to optimize the efficacy of each product candidate. Our transforming ...
based inSan Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
For the assessment of multiple sclerosis and other neurodegenerative conditions. Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to detect ...
based inMagdeburg, GERMANY
HASOMED GmbH is an owner-managed family business. We grow from our own resources, independent of outside capital, 'with our feet on the ground'. The management acts in Christian responsibility. Committed employees are the most important capital of ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
(-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
based inPortland, OREGON (USA)
APDM was founded with the objective of creating novel technologies to enable the scientific community to conduct quality research in movement science, accelerate clinical trials by introducing a new generation of biomarkers and validated endpoints, ...
based inNY, NEW YORK (USA)
We are committed to developing new areas such as mitochondrial genome sequencing, gene mutation, comparative genomics and epigenetics, and provide highly customized services. Creative Biogene provides a comprehensive range of Separation & Extraction ...
Creative Biogene provides the fractionated mitochondrial magnetic separation (FMMS) method to increase the production of brain-derived mitochondria compared with the UC method and can better detect mitochondrial damage in the central nervous system ...
based inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
We are developing an anti-tau product candidate that has the potential to address multiple neurodegenerative conditions, including AD, by targeting abnormal tau proteins alone and in potential combination with other pathological proteins such as ...
based inParis, FRANCE
Iconeus, based in Paris, is renowned for pioneering the functional ultrasound technology specifically designed for imaging cerebrovascular activity. Their flagship product, the Iconeus One, integrates high-sensitivity, high-speed, and ...
based inNew York, NEW YORK (USA)
Altucell, Inc. is a cellular engineering and biotech company backed by sound research and science focused on fulfilling a large 'unmet need' in cell, molecular and regenerative therapy for treatment of Diabetes and other autoimmune and ...
Microcapsules constitute immunoisolatory physical barriers that prevent immune rejection of the enveloped cells upon graft, while offering a special 3D Cell matrix like microenvironment (which greatly favors retention of cell viability and ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
During ReGen’s discussions with potential licensing partners in 2004, it became apparent that a product based on the Colostrinin™ complex, as a whole, was more commercially attractive as a nutraceutical, rather than as a pharmaceutical. ...
based inBozeman, MONTANA (USA)
Montana Molecular specializes in the development of fluorescent biosensors and reporters designed to facilitate drug discovery and research within living cells. With a focus on generating innovative solutions, the company provides tools that allow ...
based inCarlsbad, CALIFORNIA (USA)
Advanced Brain Monitoring is a neuro-diagnostics device company internationally recognized for its innovative technologies. Our products are used by clinicians, researchers and in clinical trials to interpret brain and physiological function as they ...
Advanced Brain Monitoring provides full service EEG for clinical trials using the StatX Series wireless EEG systems administered concurrently with a full suite of tasks, including resting state and event-related related protocols. Stat X24 combines ...
